Gary Ruoff

3.3k total citations
77 papers, 1.6k citations indexed

About

Gary Ruoff is a scholar working on Pharmacology, Physiology and Epidemiology. According to data from OpenAlex, Gary Ruoff has authored 77 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pharmacology, 18 papers in Physiology and 16 papers in Epidemiology. Recurrent topics in Gary Ruoff's work include Inflammatory mediators and NSAID effects (13 papers), Musculoskeletal pain and rehabilitation (12 papers) and Pain Mechanisms and Treatments (11 papers). Gary Ruoff is often cited by papers focused on Inflammatory mediators and NSAID effects (13 papers), Musculoskeletal pain and rehabilitation (12 papers) and Pain Mechanisms and Treatments (11 papers). Gary Ruoff collaborates with scholars based in United States, Germany and United Kingdom. Gary Ruoff's co-authors include Mark J. Lema, Norman Rosenthal, Rezaul Karim, Marc Kamin, Donna Jordan, N. Lawrence Edwards, Richard Rauck, Harold Bays, Peter H. Jones and James M. McKenney and has published in prestigious journals such as CHEST Journal, The American Journal of Medicine and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Gary Ruoff

74 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Ruoff United States 21 489 348 325 246 193 77 1.6k
E. E. Ohnhaus Germany 22 373 0.8× 312 0.9× 154 0.5× 151 0.6× 174 0.9× 67 2.0k
Robert A. Blum United States 24 470 1.0× 375 1.1× 162 0.5× 281 1.1× 88 0.5× 83 2.4k
Jim Xiang United States 22 492 1.0× 277 0.8× 498 1.5× 448 1.8× 230 1.2× 61 1.9k
Maria Caterina Pace Italy 26 422 0.9× 508 1.5× 442 1.4× 290 1.2× 384 2.0× 149 2.4k
Stéphane Mouly France 27 263 0.5× 414 1.2× 230 0.7× 317 1.3× 99 0.5× 99 2.4k
Frank Andersohn Germany 24 381 0.8× 395 1.1× 186 0.6× 422 1.7× 60 0.3× 59 2.6k
Philippe Hantson Belgium 26 192 0.4× 444 1.3× 94 0.3× 218 0.9× 160 0.8× 219 2.8k
Alfonso Carvajal Spain 20 237 0.5× 168 0.5× 105 0.3× 144 0.6× 84 0.4× 63 1.6k
Maria Beatrice Passavanti Italy 20 219 0.4× 301 0.9× 279 0.9× 164 0.7× 215 1.1× 96 1.3k
Andis Graudins Australia 32 481 1.0× 405 1.2× 105 0.3× 113 0.5× 361 1.9× 126 3.1k

Countries citing papers authored by Gary Ruoff

Since Specialization
Citations

This map shows the geographic impact of Gary Ruoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Ruoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Ruoff more than expected).

Fields of papers citing papers by Gary Ruoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Ruoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Ruoff. The network helps show where Gary Ruoff may publish in the future.

Co-authorship network of co-authors of Gary Ruoff

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Ruoff. A scholar is included among the top collaborators of Gary Ruoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Ruoff. Gary Ruoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Derosier, Frederick J., Fred D. Sheftell, Stephen D. Silberstein, et al.. (2011). Sumatriptan‐Naproxen and Butalbital: A Double‐Blind, Placebo‐Controlled Crossover Study. Headache The Journal of Head and Face Pain. 52(4). 530–543. 20 indexed citations
2.
Ruoff, Gary. (2010). Assessing Pain as the Fifth Vital Sign. Postgraduate Medicine. 122(6). 4–7. 3 indexed citations
3.
Fennerty, M. Brian, Pamela Kushner, David A. Peura, et al.. (2009). Short- and long-term management of heartburn and other acid-related disorders: development of an algorithm for primary care providers.. PubMed. 58(7 Suppl Short). S1–12. 4 indexed citations
4.
Brown, Jeffrey S., Peter J. Neumann, George Papadopoulos, et al.. (2007). Migraine Frequency and Health Utilities: Findings from a Multisite Survey. Value in Health. 11(2). 315–321. 22 indexed citations
5.
Winner, Paul, Roger Cady, Gary Ruoff, et al.. (2007). Twelve-Month Tolerability and Safety of Sumatriptan-Naproxen Sodium for the Treatment of Acute Migraine. Mayo Clinic Proceedings. 82(1). 61–68. 21 indexed citations
6.
McKenney, James M., Peter H. Jones, Harold Bays, et al.. (2007). Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study). Atherosclerosis. 192(2). 432–437. 120 indexed citations
7.
Bingham, Clifton O., Anthony Sebba, Gary Ruoff, et al.. (2006). Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. Lara D. Veeken. 46(3). 496–507. 94 indexed citations
8.
Ruoff, Gary. (2005). Evidence-Based Cardiovascular Disease Prevention: Challenges to Assessing Risk in Office Practice. 45(13). 1467–1474.
9.
Kudrow, David, Hallie Thomas, Gary Ruoff, et al.. (2005). Valdecoxib for Treatment of a Single, Acute, Moderate to Severe Migraine Headache. Headache The Journal of Head and Face Pain. 45(9). 1151–1162. 19 indexed citations
10.
Birbara, C., Gary Ruoff, Eric Sheldon, et al.. (2005). Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies. Current Medical Research and Opinion. 22(1). 199–210. 20 indexed citations
11.
Ruoff, Gary & Mark J. Lema. (2003). Strategies in Pain Management. Journal of Pain and Symptom Management. 25(2). 21–31. 66 indexed citations
12.
Ruoff, Gary, Norman Rosenthal, Donna Jordan, Rezaul Karim, & Marc Kamin. (2003). Tramadol/Acetaminophen combination tablets for the treatment of chronic lower back pain: A multicenter, randomized, double-blind, placebo-controlled outpatient study. Clinical Therapeutics. 25(4). 1123–1141. 146 indexed citations
13.
Ruoff, Gary. (2002). Challenges of managing chronic pain in the elderly☆, ☆☆. Seminars in Arthritis and Rheumatism. 32(3). 43–50. 21 indexed citations
14.
Sacks, Stephen L., Ronald A. Thisted, Terry M. Jones, et al.. (2001). Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial. Journal of the American Academy of Dermatology. 45(2). 222–230. 75 indexed citations
15.
Ruoff, Gary & Laura Schaffner Gray. (1999). Using a flow sheet to improve performance in treatment of elderly patients with type 2 diabetes.. PubMed. 31(5). 331–6. 20 indexed citations
16.
Ruoff, Gary. (1999). Slowing the Initial Titration Rate of Tramadol Improves Tolerability. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(1). 88–93. 56 indexed citations
17.
Adelglass, Jeffrey, Terry M. Jones, Gary Ruoff, et al.. (1998). A Multicenter, Investigator‐Blinded, Randomized Comparison of Oral Levofloxacin and Oral Clarithromycin in the Treatment of Acute Bacterial Sinusitis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 18(6). 1255–1263. 41 indexed citations
18.
Ruoff, Gary. (1998). Management of pain in patients with multiple health problems: a guide for the practicing physician. The American Journal of Medicine. 105(1). 53S–60S. 19 indexed citations
19.
Dörsam, J., et al.. (1989). Experiences in Home Care of Cancer Patients A new approach in cancer nursing. Acta Oncologica. 28(1). 35–38. 4 indexed citations
20.
Guthrie, Robert, et al.. (1988). Aetiology of Acute Pharyngitis and Clinical Response to Empirical Therapy with Erythromycin Versus Amoxicillin. Family Practice. 5(1). 29–35. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. E. Ohnhaus Breakdown of academic impact, for papers by Robert A. Blum Breakdown of academic impact, for papers by Jim Xiang Breakdown of academic impact, for papers by Maria Caterina Pace Breakdown of academic impact, for papers by Stéphane Mouly Breakdown of academic impact, for papers by Frank Andersohn Breakdown of academic impact, for papers by Philippe Hantson Breakdown of academic impact, for papers by Alfonso Carvajal Breakdown of academic impact, for papers by Maria Beatrice Passavanti Breakdown of academic impact, for papers by Andis Graudins
Rankless by CCL
2026